Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.
J Headache Pain. 2021 Dec 18;22(1):154. doi: 10.1186/s10194-021-01363-y.
J Headache Pain. 2021.
PMID: 34922444
Free PMC article.